♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

561 Tranexamic acid is safe and effective for orthopaedic oncology patients: a retrospective review of 599 patients undergoing lower-extremity endoprosthetic reconstruction ♢

Author:Stephen Chenard, MSc  William Hefley  Akhil Rekulapelli, BS  Riley Gilbertson, BA  Connor Charton, MSc, BS  Rajul Gupta, MS (ORTH)  Herbert Schwartz, MD, FAAOS  Jennifer Halpern, MD, FAAOS  John Martin, MD  Jonathan Schoenecker, MD, FAAOS  Joshua Lawrenz, MD, FAAOS  

Event Title:Paper Presentations  

Event Type:Paper Presentations  

Category-Classification:Musculoskeletal Oncology  

Event Day:Thursday, March 5  

P372 Are We on the Same Page? Defining Consensus for Pediatric Open Fracture Management Among Level 1 Pediatric Trauma Centers

Author:Kristin Livingston, MD, FAAOS  Keith Baldwin, MD, FAAOS  Todd Blumberg, MD, FAAOS  Lawson Copley, MD, FAAOS  Jaime Denning, MD, FAAOS  Rachel Goldstein, MD, MPH, FAAOS  Jaclyn Hill, MD, FAAOS  Megan Johnson, MD, FAAOS  Allen Kadado, MD, FAAOS  Jill Larson, MD, FAAOS  G. Li, MD, FAAOS  Jessica McGraw-Heinrich, MD  Mark Miller, MD, FAAOS  Joshua Murphy, MD, FAAOS  Jonas Owen, MD, FAAOS  Anthony Riccio, MD, FAAOS  Jonathan Schoenecker, MD, FAAOS  Benjamin Sheffer, MD, FAAOS  Christopher Souder, MD, FAAOS  Matthew Stepanovich, MD, FAAOS  Ishaan Swarup, MD, FAAOS  Vidyadhar Upasani, MD, FAAOS  Julia Sanders, MD, FAAOS  Allan Beebe, MD, FAAOS  Dell McLaughlin, MD, MPH, FAAOS  Nathaniel Lempert, MD  Benjamin Shore, MD, MPH, FAAOS, FRCSC  

Event Title:Posters  

Event Type:Posters  

Category-Classification:Pediatrics  

Event Day:Wednesday, March 4